From revenue to R&D investment, Novo and Lilly and their mega-blockbuster weight loss drugs Zepbound and Wegovy have moved ...

Eli Lilly (LLY) investors should expect fireworks this week as the pharma giant prepares to drop its bombshell Q4 2024 ...

There’s also a new group of younger friends, the self-proclaimed “Mini Magnolias.” Last season, Dana Sue’s 16-year-old ...

Lily Crago has immersed herself in politics since she was a child. Between her experiences at Girls State and Girls Nation ...

Cedar Rapids Xavier, Cedar Rapids Prairie pursue outright MVC championships Friday. Saints host Iowa City West, which has an ...

Eli Lilly, BCE, Suncor, Canada Goose, Bombardier, Thomson Reuters and Lightspeed reported earnings this week. Here are the ...

Men’s basketball (10-9, 2-4 Ivy League) split their two games this weekend, using a late push to hold off Penn (6-13, 2-4) 88 ...

Sales of Lilly’s top-selling product, the diabetes treatment Mounjaro, jumped 60% to $3.53 billion in the final quarter of ...

Eli Lilly And Cao (NYSE:LLY) announced the results from the VIVID-2 open-label extension study of Omvoh (mirikizumab-mrkz).

The med's obesity counterpart, Zepbound, reeled in $1.9 billion during the quarter ... startled investors, sending Lilly’s stock down about 6.5% on the day of the announcement.